Patents Examined by Patricia C. Mallari
  • Patent number: 7946995
    Abstract: A system and method of determining the status of an adverse cardiac condition of a medical patient based on circadian variation of one or more hemodynamic parameters are provided. In some embodiments, the system and method calculate a first average value of a series of first values during a first time period, a second average value of a series of second values during a second time period, and a difference between the first average value and the second average value. The method provides an indication of an adverse cardiac condition when the difference is less than a predetermined threshold.
    Type: Grant
    Filed: November 9, 2006
    Date of Patent: May 24, 2011
    Assignee: Pacesetter, Inc.
    Inventors: Steve Koh, Euljoon Park, Dorin Panescu
  • Patent number: 7949381
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: May 24, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, James H. Brauker
  • Patent number: 7946984
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: May 24, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, James R. Petisce, James Patrick Thrower, Sean Saint, John Nolting
  • Patent number: 7946996
    Abstract: An introducer sheath/temperature probe assembly that is insertable into a blood vesel of a human or veterinary patent to measure the temperature of blood flowing through that blood vessel. The introducer sheath/temperature probe assembly may be used in conjunction with an indwelling heat exchange catheter system to warm or cool all or a portion of the patient's body to a desired target temperature and to maintain such target temperature for a desired period of time.
    Type: Grant
    Filed: February 20, 2007
    Date of Patent: May 24, 2011
    Assignee: ZOLL Circulation, Inc.
    Inventors: Jeffrey P. Callister, Michael W. Dae, Amy L. Hammack
  • Patent number: 7935062
    Abstract: The present invention provides a system and method for estimating a blood flow waveform contour from a pressure signal. An arterial or ventricular pressure signal is acquired from a pressure sensor. Landmark points are identified on the pressure waveform that correspond to features of a flow waveform. In one embodiment, the landmark pressure waveform points correspond to the onset of flow, the peak flow, and the end of the systolic ejection phase. The landmark pressure waveform points define a contour that approximates the flow contour. Beat-by-beat flow contour estimation can be performed to allow computation of flow-related hemodynamic parameters such as stroke volume or cardiac output for use in patient monitoring and/or therapy management.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: May 3, 2011
    Assignee: Medtronic, Inc.
    Inventors: Mustafa Karamanoglu, Tommy D. Bennett
  • Patent number: 7931597
    Abstract: An anchored implantable pressure monitor.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: April 26, 2011
    Assignee: Vital Sensors Holding Company, Inc.
    Inventors: Volker Bodecker, Max Georg Ostermeier, Stefan Meyer, Axel Niemeyer
  • Patent number: 7931598
    Abstract: An implantable pressure monitor.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: April 26, 2011
    Assignee: Vital Sensors Holding Company, Inc.
    Inventors: Volker Bodecker, Max Georg Ostermeier, Stefan Meyer, Axel Niemeyer
  • Patent number: 7927282
    Abstract: A pressure sensor is deployed in the right atrium and is in contact with the tissue of the fossa ovalis. The fossa ovalis acts as a membrane and the pressure sensor determines the relative and/or absolute pressure within the left atrium while remaining within the right atrium. A variety of embodiment are provided to deploy and anchor the sensor into the proper position.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: April 19, 2011
    Assignee: Medtronic, Inc.
    Inventors: Douglas A. Hettrick, Todd M. Zielinski
  • Patent number: 7914460
    Abstract: The present invention provides systems and methods for analyzing glucose present in exhaled breath condensate (EBC). In certain embodiments of the invention, electrochemical- or coulometric-based sensing technologies are used to analyze EBC for the presence and/or concentration of glucose.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: March 29, 2011
    Assignees: University of Florida Research Foundation, Inc., Xhale, Inc.
    Inventors: Richard J. Melker, David G. Bjoraker, Donn M. Dennis, Jon D. Stewart, Christopher D. Batich, Matthew M. Booth, John Frederick Horn, Jr., Ronald E. Youngblood
  • Patent number: 7912525
    Abstract: A method and apparatus for enhancing the integrity of an implantable sensor. Voids formed between an outer tubing and a sensor substrate or spacing element may be back-filled with a curable, implantable material, minimizing the extent to which unwanted fluids diffuse within the sensor. An enzyme or protein matrix pellet below the sensor window may be pre-treated with a reducing agent to enhance its bond stability, and to reduce undesired swelling that may cause the sensor window to detach or leak. The bonding between the enzyme pellet and a hydrogel layer may be reinforced by application of an intervening bonding layer of a protein material, such as human serum albumin (HSA). The size of the window may be minimized by minimizing the size of an underlying electrode, providing reduced flux and lengthening sensor. A coating may be deposited on the surface of the sensor leads, providing stiffening and lubrication.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: March 22, 2011
    Assignee: Medtronic Minimed, Inc.
    Inventors: Rajiv Shah, Yanan Zhang, Rebecca Gottlieb, Bahar Reghabi, Michael Miller
  • Patent number: 7909768
    Abstract: Methods, systems and devices are provided for reducing the amount of data, processing and/or power required to analyze hemodynamic signals such as photoplethysmography (PPG) signals, pressure signals, and impedance signals. In response to detecting a specific event associated with a cyclical body function, a hemodynamic signal is continuously sampled during a window following the detecting of the specific event, wherein the window is shorter than a cycle associated with the cyclical body function. The hemodynamic signal is then analyzed based on the plurality of samples.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: March 22, 2011
    Assignee: Pacesetter, Inc.
    Inventor: Robert G. Turcott
  • Patent number: 7905833
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: March 15, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Steve Masterson, J. Michael Dobbles, Michael Robert Mensinger, Sean Saint, Apurv Ullas Kamath, James Brauker, James Patrick Thrower
  • Patent number: 7901354
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: March 8, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • Patent number: 7899511
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: March 1, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
  • Patent number: 7899524
    Abstract: Methods for determining whether the brain activity of a human subject in response to a stimulus of interest or question of interest is characteristic of a state of interest, such as a deceptive state or a truthful state, are disclosed. Some methods include the use of control questions, including truthful control questions and deceptive control questions, to provide bases for comparison for responses to stimuli of interest or questions of interest. Some methods include the use of differences between two states, such as a deceptive state and a truthful state. In some methods, brain maps are generated and compared. Also disclosed are systems for detecting deception by measuring brain activity.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: March 1, 2011
    Assignee: MUSC Foundation for Research and Development
    Inventor: Frank Andrew Kozel
  • Patent number: 7896813
    Abstract: A system and method for monitoring in a patient includes producing sensor signals representative of a physiologic parameter associated with respiration. A periodic breathing cycle is detected based on the sensor signals. An output is produced as a function of the cycle length.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: March 1, 2011
    Assignee: Medtronic, Inc.
    Inventors: Sameh Sowelam, H. Toby Markowitz, Mark K. Erickson, Ioana Nicolaescu
  • Patent number: 7887493
    Abstract: Methods and systems for evaluating a pathological condition include acquiring movement information, such as electromyogram (EMG) information, and sleep disordered breathing (SDB) information, and detecting the presence of a pathological condition using both movement and SDB information. Methods may involve sensing physiological signals including at least muscle movement signals. Sleep-related disorders are detected using the sensed physiological signals, the sleep-related disorders including at least an involuntary muscle movement disorder and sleep-disordered breathing. Methods and systems also provide for detecting and treating a sleep-related disorder using movement and SDB information. Cardiac, respiratory, nerve stimulation, drug, or a combination of such therapies may be delivered to treat a detected or diagnosed pathological condition.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: February 15, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jeffrey E. Stahmann, Jesse W. Hartley, Kent Lee, Quan Ni
  • Patent number: 7885697
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: February 8, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, James H. Brauker, James Patrick Thrower
  • Patent number: 7878975
    Abstract: An apparatus for indicating a health-related condition of a subject has an input interface for receiving a sequence of samples of a first biological quantity derived by a first measurement method, the first measurement method being an invasive measurement and having a first impact on the subject, and for receiving a sequence of samples of a second biological quantity derived by a second measurement method, the second measurement method being a non-invasive measurement and having a second impact on the subject, wherein the first biological quantity gives a more accurate indication of the health-related condition of the subject than the second biological quantity, wherein the first biological quantity and the second biological quantity have a correlation to the health-related condition of the subject, and wherein the second impact is smaller than the first impact; a predictor for providing, for a certain time, for which no sample for the first biological quantity exists, an estimated value of the first biologic
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: February 1, 2011
    Assignee: Diabetes Tools Sweden AB
    Inventors: Lars Gustaf Liljeryd, Ulf Frederik Magnusson
  • Patent number: 7878980
    Abstract: A gas flow diverter for increasing the turbulence of an incoming respiratory gas flow through a respiratory gas sensor is provided. The diverter is positioned at a patient or inlet end of a tube section of the sensor in order to divert the respiratory gas flow from the patient generally equally across the cross-sectional area of the tube section. The diverter can be formed integrally as a part of the sensor, or can be releasably attached to the sensor or to an adapter that is releasably connected to the inlet end of the sensor for use in situations in which the volume of the incoming respiratory gas flow from the patient is greatly reduced due to the size of the patient, i.e., when the patient is an infant.
    Type: Grant
    Filed: June 8, 2004
    Date of Patent: February 1, 2011
    Assignee: Treymed, Inc.
    Inventor: Robert H. Ricciardelli